Table 2.

Number of patients having nonhematologic toxicity after treosulfan and fludarabine conditioning



CTC grade (%)

0
1
2
3
4
Nausea   5 (17)   17 (57)   8 (27)   0   0  
Vomiting   9 (30)   11 (37)   9 (30)   1 (3)   0  
Mucositis   10 (33)   14 (47)   6 (20)   0   0  
Creatinine   14 (43)   10 (33)   6 (20)   0   0  
ALT/AST   2 (7)   9 (30)   9 (30)   10 (33)   0  
Bilirubin   9 (30)   11 (37)   5 (17)   4 (13)   1 (3)  
Alkaline phosphatase   13 (43)   13 (43)   4 (13)   0   0  
Diarrhea   11 (37)   9 (30)   7 (23)   3 (10)   0  
Constipation   20 (67)   1 (3)   8 (27)   1 (3)   0  
Fever without neutropenia   14 (43)   9 (30)   5 (17)   1 (3)   1 (3)  
Fever with neutropenia   14 (43)   0   0   16 (57)   0  
Infection   6 (20)   0   0   22 (73)   2 (7)  
Confusion   28 (94)   0   1 (3)   1 (3)   0  
Polyneuropathy, sensory   26 (87)   3 (10)   0   1 (3)   0  
Polyneuropathy, motor   29 (97)   0   0   1 (3)   0  
Pain
 
9 (30)
 
6 (20)
 
15 (50)
 
0
 
0
 


CTC grade (%)

0
1
2
3
4
Nausea   5 (17)   17 (57)   8 (27)   0   0  
Vomiting   9 (30)   11 (37)   9 (30)   1 (3)   0  
Mucositis   10 (33)   14 (47)   6 (20)   0   0  
Creatinine   14 (43)   10 (33)   6 (20)   0   0  
ALT/AST   2 (7)   9 (30)   9 (30)   10 (33)   0  
Bilirubin   9 (30)   11 (37)   5 (17)   4 (13)   1 (3)  
Alkaline phosphatase   13 (43)   13 (43)   4 (13)   0   0  
Diarrhea   11 (37)   9 (30)   7 (23)   3 (10)   0  
Constipation   20 (67)   1 (3)   8 (27)   1 (3)   0  
Fever without neutropenia   14 (43)   9 (30)   5 (17)   1 (3)   1 (3)  
Fever with neutropenia   14 (43)   0   0   16 (57)   0  
Infection   6 (20)   0   0   22 (73)   2 (7)  
Confusion   28 (94)   0   1 (3)   1 (3)   0  
Polyneuropathy, sensory   26 (87)   3 (10)   0   1 (3)   0  
Polyneuropathy, motor   29 (97)   0   0   1 (3)   0  
Pain
 
9 (30)
 
6 (20)
 
15 (50)
 
0
 
0
 
Close Modal

or Create an Account

Close Modal
Close Modal